​
​

PMV Pharmaceuticals Ownership | Who Owns PMV Pharmaceuticals?

OverviewForecastRevenueFinancialsChart

PMV Pharmaceuticals Ownership Summary

PMV Pharmaceuticals is owned by 78.71% institutional investors, 2.30% insiders, and 18.99% retail investors. Orbimed advisors is the largest institutional shareholder, holding 12.59% of PMVP shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.95% of its assets in PMV Pharmaceuticals shares.

PMVP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPMV Pharmaceuticals78.71%2.30%18.99%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors6.48M12.59%$10.49M
Arrowmark colorado2.80M5.45%$4.54M
Sio capital management2.71M5.26%$4.39M
Euclidean capital2.63M5.11%$4.26M
Alkeon capital management2.35M4.56%$3.80M
Vanguard group2.28M4.44%$3.70M
Acadian asset management2.08M4.04%$3.37M
Bml capital management1.31M2.55%$2.12M
Pfm health sciences, lp1.28M2.48%$2.07M
Blackrock1.16M2.26%$1.88M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management1.31M1.51%$2.12M
Sio capital management2.71M1.19%$4.39M
Euclidean capital2.63M0.53%$4.26M
Aldebaran capital351.24K0.53%$569.01K
Acuitas investments353.75K0.31%$573.07K
Orbimed advisors6.48M0.21%$10.49M
Personal cfo solutions550.34K0.14%$891.55K
Evoke wealth63.23K0.12%$102.44K
Pfm health sciences, lp1.28M0.10%$2.07M
Arrowmark colorado2.80M0.05%$4.54M

Top Buyers

HolderShares% AssetsChange
Sio capital management2.71M1.19%2.71M
Aldebaran capital351.24K0.53%351.24K
D. e. shaw1.02M0.00%298.99K
Rbf capital253.36K0.02%253.36K
Assenagon asset management260.03K0.00%189.21K

Top Sellers

HolderShares% AssetsChange
Blackrock1.16M--1.95M
Bank of america corp /de/340.39K--1.03M
State street145.08K--640.91K
Ecor1 capital---566.88K
Geode capital management427.72K0.00%-475.41K

New Positions

HolderShares% AssetsChangeValue
Sio capital management2.71M1.19%2.71M$4.39M
Aldebaran capital351.24K0.53%351.24K$569.01K
Rbf capital253.36K0.02%253.36K$410.44K
Qube research71.70K0.00%71.70K$116.16K
Evoke wealth63.23K0.12%63.23K$102.44K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-8.00
Avion wealth-299.00
Capital advisors-322.00
New york state common retirement fund-341.00
Private wealth management group-676.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202493-7.00%40,490,486-5.27%781.14%45-10.00%3119.23%
Mar 31, 2024100-2.91%42,741,191-8.02%830.93%50-13.79%26-13.33%
Dec 31, 2023103-8.04%46,466,060-14.33%940.68%5818.37%30-11.76%
Sep 30, 20231122.75%54,236,2714.79%1180.93%49-15.52%3417.24%
Jun 30, 2023109-6.03%51,759,5220.48%1130.89%581.75%29-21.62%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.52M2.95%-
ArrowMark Small Cap Gro1.26M2.44%-
Meridian Small Cap Growth Legacy1.26M2.44%-
Vanguard Institutional Extnd Mkt Idx Tr540.35K1.05%-
SQUAD Aguja Opportunities I450.00K0.87%150.00K
BlackRock Advantage Small Cap Core Instl280.44K0.54%-
Goldman Sachs Small Cp Val Insghts Instl249.01K0.48%-
Fidelity Extended Market Index237.83K0.46%427.00
Bridgeway Ultra-Small Company Market139.90K0.27%64.90K
Vanguard Health Care ETF140.02K0.27%2.32K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 11, 2024Jalota Deepika Chief Development OfficerSell$10.85K
Sep 11, 2024Carulli Michael Chief Financial OfficerSell$4.35K
Nov 22, 2023ORBIMED ADVISORS LLC-Sell$195.76K
Sep 15, 2023Jalota Deepika Chief Development OfficerSell$27.17K
Sep 15, 2023Alland Leila Chief Medical OfficerSell$41.65K

Insider Transactions Trends

DateBuySell
2024 Q3-2
2024 Q2--
2024 Q1--
2023 Q4-1
2023 Q3-2

PMVP Ownership FAQ

Who Owns PMV Pharmaceuticals?

PMV Pharmaceuticals shareholders are primarily institutional investors at 78.70%, followed by 2.30% insiders and 19.00% retail investors. The average institutional ownership in PMV Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which PMV Pharmaceuticals exceeds.

Who owns the most shares of PMV Pharmaceuticals?

PMV Pharmaceuticals’s largest shareholders are Orbimed advisors (6.48M shares, 12.59%), Arrowmark colorado (2.8M shares, 5.45%), and Sio capital management (2.71M shares, 5.26%). Together, they hold 23.30% of PMV Pharmaceuticals’s total shares outstanding.

Does Blackrock own PMV Pharmaceuticals?

Yes, BlackRock owns 2.26% of PMV Pharmaceuticals, totaling 1.16M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.88M$. In the last quarter, BlackRock decreased its holdings by -1.948M shares, a -62.63% change.

Who is PMV Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is PMV Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.51% of its assets in 1.31M PMV Pharmaceuticals shares, valued at 2.12M$.

Who is the top mutual fund holder of PMV Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of PMV Pharmaceuticals shares, with 2.95% of its total shares outstanding invested in 1.52M PMV Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools